ZURICH, May 4 (Reuters) - Actelion will appeal the final jury verdict in a licensing agreement dispute with Japanese group Asahi Kasei <3407.T>, the Swiss biotech group said on Wednesday, helping to ...

The Justice Department alleged that Actelion Pharmaceuticals violated federal law by using a foundation fund to funnel kickback payments aimed at inducing patients to buy its drugs. Actelion was ...

An industrywide probe of pharma's charitable contributions has spawned multimillion-dollar kickback settlements, and Actelion is the latest to make a deal with the feds. The Johnson & Johnson unit ...

BOSTON-- The U.S. Attorney's Office announced today that pharmaceutical company Actelion Pharmaceuticals US, Inc. (Actelion), a seller of pulmonary arterial hypertension (PAH) drugs, has agreed to pay ...

On Tuesday, Johnson & Johnson JNJ announced that it has ended talks regarding a possible transaction with Swiss biotechnology company, Actelion Ltd. ALIOF, reportedly for a disagreement over the ...

BOSTON – A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients. The U.S. attorney's office in Boston ...

CER percentage changes are calculated by reconsolidating both the H1 2014 and H1 2015 results at constant currencies (the average monthly exchange rates for H1 2014). Actelion continues to measure, ...

Idorsia founder and CEO Jean-Paul Clozel said his biotech group has the resources to assess trial data and decide what to do with assets, as spending on projects led to a 386 million Swiss franc ($385 ...